Mirum Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	521.31	336.89	186.37	77.06	19.14
Revenue Growth (YoY)	54.74%	80.76%	141.85%	302.67%	-
Cost of Revenue	100.24	81.64	47.04	12.37	1.9
Gross Profit	421.07	255.25	139.34	64.69	17.24
Selling, General & Admin	257.03	202.22	145.88	89.07	59.22
Research & Development	186.18	140.63	102.61	106.84	131.43
Total Operating Expenses	443.21	342.85	248.49	195.91	190.65
Operating Income	-22.14	-87.61	-109.15	-131.22	-173.41
Interest Income	12.73	13.79	13.74	3.86	0.37
Interest Expense	-14.39	-14.31	-15.11	-15.98	-17.59
Other Non-Operating Income (Expense)	2.37	1.21	-51.9	1.27	106.69
Total Non-Operating Income (Expense)	0.71	0.69	-53.27	-10.85	89.46
Pretax Income	-21.43	-86.91	-162.42	-142.07	-83.95
Provision for Income Taxes	1.94	1.03	0.99	-6.41	0.04
Net Income	-23.36	-87.94	-163.42	-135.67	-83.99
Net Income to Common	-23.36	-87.94	-163.42	-135.67	-83.99
Shares Outstanding (Basic)	50	48	41	34	30
Shares Outstanding (Diluted)	50	48	41	34	30
Shares Change (YoY)	5.63%	16.23%	20.31%	12.07%	20.08%
EPS (Basic)	-0.47	-1.85	-4.00	-4.01	-2.77
EPS (Diluted)	-0.47	-1.85	-4.00	-4.02	-2.77
Free Cash Flow	54.87	9.33	-71.05	-120.41	-132.78
Free Cash Flow Growth	488.01%	-	-	-	-
Free Cash Flow Per Share	1.09	0.20	-1.74	-3.54	-4.38
Gross Margin	80.77%	75.77%	74.76%	83.94%	90.06%
Operating Margin	-4.25%	-26.00%	-58.57%	-170.28%	-906.12%
Profit Margin	-4.48%	-26.10%	-87.68%	-176.05%	-438.85%
FCF Margin	10.53%	2.77%	-38.12%	-156.26%	-693.81%
EBITDA	2.11	-63.98	-98.33	-127.98	-172.82
EBITDA Margin	0.40%	-18.99%	-52.76%	-166.08%	-903.01%
EBIT	-22.14	-87.61	-109.15	-131.22	-173.41
EBIT Margin	-4.25%	-26.00%	-58.57%	-170.28%	-906.12%
Effective Tax Rate	-9.04%	-1.19%	-0.61%	4.51%	-0.04%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q